Accessibility Arrangements by Teva
Teva makes its best efforts and invests many resources in order to provide all our customers with an equal, respectful, accessible and professional service. Considerable effort and resources are invested in making the necessary accessibility adjustments that will enable individuals with disabilities to receive the services provided to all customers independently and equitably.
Accessible Customer Service:
You may contact us through the details provided in the “Contact Us” page of this website, or by using the email detailed below.
Website Accessibility Information:
Teva believes in and operates to advance equal opportunities on the internet for individuals with disabilities and people using assistive technology.
The website is designed and maintained following the Web Content Accessibility Guidelines (WCAG) 2.1 for online content accessibility at AA level.
Online testing is checked for the highest compatibility for use with a Chrome browser.
The site provides a semantic structure for assistive technologies and support for the customizable keyboard usage pattern with the arrow keys, Enter and Esc to exit from menus and windows.
The site is periodically optimized for display in common browsers and mobile phone use.
For the best browsing experience with screen reading software, we recommend using the latest NVDA software.
Accessibility Requests and Suggestions for Accessibility Improvements
We are engaged in ongoing efforts to enhance the accessibility of the website as part of our commitment to enable the entire population, including individuals with disabilities, to receive our services.
If you encounter any accessibility problem or malfunction while using the website or you want to provide feedback about the accessibility of the website, please let us know, and we will make every effort to find a suitable solution for you and address the issue as soon as possible.
Contact the Accessibility Coordinator at Teva:
Robyn Feingold: Robyn.Feingold@tevapharm.com
Publication of the Accessibility Statement:
Updated: November 2022